Published in Parasitol Res on August 17, 2007
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Natural products as sources of new drugs over the last 25 years. J Nat Prod (2007) 13.98
Biology of Trypanosoma cruzi. Annu Rev Microbiol (1973) 4.13
GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA. Rev Inst Med Trop Sao Paulo (1964) 4.09
Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol (2006) 2.44
In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol (1985) 2.20
Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res (1991) 2.06
Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz (2003) 2.04
Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis. Curr Med Chem (2006) 1.25
Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med (1999) 1.00
Trypanocidal tetrahydrofuran lignans from inflorescences of Piper solmsianum. Phytochemistry (2003) 0.98
Anti-leishmanial activity of neolignans from Virola species and synthetic analogues. Phytochemistry (2000) 0.97
Antifungal, antiprotozoal, cytotoxic and piscicidal properties of Justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum. Planta Med (2003) 0.94
In vitro evaluation of antifungal properties of 8.O.4'-neolignans. J Nat Prod (1997) 0.89
Flavonoids and lignans from Virola surinamensis twigs and their in vitro activity against Trypanosoma cruzi. Planta Med (1998) 0.89
Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett (2005) 0.88
Activity of neolignans isolated from Piper regnellii (MIQ.) C. DC. var. pallescens (C. DC.) YUNCK against Trypanosoma cruzi. Biol Pharm Bull (2006) 0.88
Trypanocidal constituents in plants 1. Evaluation of some Mexican plants for their trypanocidal activity and active constituents in Guaco, roots of Aristolochia taliscana. Biol Pharm Bull (2002) 0.87
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes. J Nat Prod (1999) 0.86
Tetrahydrofuran lignans from Nectandra megapotamica with trypanocidal activity. J Nat Prod (2004) 0.78
In vitro studies on mode of action of antifungal 8.O.4'-neolignans occurring in certain species of Virola and related genera of Myristicaceae. J Ethnopharmacol (1998) 0.78
Antitrypanosomal activity of a novel norlignan purified from Nectandra lineata. Nat Prod Res (2005) 0.77
Neolignans inhibit Trypanosoma cruzi infection of its triatomine insect vector, Rhodnius prolixus. Parasitol Res (1999) 0.77
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. Bioorg Med Chem (2006) 1.32
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi. J Agric Food Chem (2004) 1.11
Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int J Pharm (2005) 1.05
Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples. J Clin Microbiol (2003) 0.99
Characterization of an omega-class glutathione S-transferase from Schistosoma mansoni with glutaredoxin-like dehydroascorbate reductase and thiol transferase activities. Eur J Biochem (2002) 0.95
A rapid TLC autographic method for the detection of xanthine oxidase inhibitors and superoxide scavengers. Phytochem Anal (2006) 0.94
Value of the ethnomedical information for the discovery of plants with antifungal properties. A survey among seven Latin American countries. J Ethnopharmacol (2009) 0.92
Antifungal properties of novel N- and alpha,beta-substituted succinimides against dermatophytes. Arzneimittelforschung (2003) 0.92
An unusual homoisoflavanone and a structurally-related dihydrochalcone from Polygonum ferrugineum (Polygonaceae). Phytochemistry (2006) 0.88
Cloning, characterization and subcellular localization of a Trypanosoma cruzi argonaute protein defining a new subfamily distinctive of trypanosomatids. Gene (2010) 0.87
Structure-activity relationship study of homoallylamines and related derivatives acting as antifungal agents. Bioorg Med Chem (2005) 0.86
In vitro antifungal activity of polyfunctionalized 2-(hetero)arylquinolines prepared through imino Diels-Alder reactions. Bioorg Med Chem (2008) 0.85
Chemically engineered extracts as an alternative source of bioactive natural product-like compounds. Proc Natl Acad Sci U S A (2006) 0.84
Synthesis and conformational analysis of His-Phe-Arg-Trp-NH2 and analogues with antifungal properties. Bioorg Med Chem (2006) 0.83
Trypanosoma cruzi bromodomain factor 2 (BDF2) binds to acetylated histones and is accumulated after UV irradiation. Int J Parasitol (2008) 0.83
Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice. Life Sci (2004) 0.81
Characterization of TcHMGB, a high mobility group B family member protein from Trypanosoma cruzi. Int J Parasitol (2011) 0.80
New small-size peptides possessing antifungal activity. Bioorg Med Chem (2009) 0.80
Evolution of renal function and Na+, K +-ATPase expression during ischaemia-reperfusion injury in rat kidney. Mol Cell Biochem (2006) 0.80
Beneficial effects of benznidazole during an infectious-based situation of systemic inflammatory response: cecal ligation and puncture. Am J Trop Med Hyg (2008) 0.79
Benznidazole blocks NF-kappaB activation but not AP-1 through inhibition of IKK. Mol Immunol (2010) 0.79
Visceral involvement due to Leishmania mexicana in a patient with acquired immunodeficiency syndrome. Am J Med (2002) 0.79
Benznidazole treatment attenuates liver NF-κB activity and MAPK in a cecal ligation and puncture model of sepsis. Mol Immunol (2011) 0.79
Schistosoma mansoni ferredoxin NADP(H) oxidoreductase and its role in detoxification. Mol Biochem Parasitol (2002) 0.79
Novel cytostatic activity of the trypanocidal drug Benznidazole. Int Immunopharmacol (2009) 0.78
Antifungal activity of Heterothalamus alienus metabolites. Phytother Res (2008) 0.78
Isolation of antifungal saponins from Phytolacca tetramera, an Argentinean species in critic risk. J Ethnopharmacol (2002) 0.78
Novel antifungal agents: a patent review (2011 - present). Expert Opin Ther Pat (2014) 0.78
Antifungal activity of saponin-rich extracts of Phytolacca dioica and of the sapogenins obtained through hydrolysis. Nat Prod Commun (2010) 0.78
In vitro antifungal properties structure-activity relationships and studies on the mode of action of N-phenyl, N-aryl, N-phenylalkyl maleimides and related compounds. Arzneimittelforschung (2005) 0.77
Schistosoma mansoni: ferredoxin-NADP(H) oxidoreductase and the metabolism of reactive oxygen species. Exp Parasitol (2005) 0.77
Spliced leader RNA gene promoter sequence heterogeneity in CL-Brener Trypanosoma cruzi reference strain. Infect Genet Evol (2004) 0.77
Synthesis, antifungal and antitumor activity of novel (Z)-5-hetarylmethylidene-1,3-thiazol-4-ones and (z)-5-ethylidene-1,3-thiazol-4-ones. Molecules (2013) 0.77
Efficient synthesis of novel 3-aryl-5-(4-chloro-2-morpholinothiazol-5-yl)-4,5-dihydro-1H-pyrazoles and their antifungal activity alone and in combination with commercial antifungal agents. Arch Pharm (Weinheim) (2014) 0.77
One-tube nested polymerase chain reaction for detection of Chlamydia trachomatis. Mem Inst Oswaldo Cruz (2002) 0.77
Trypanosoma cruzi TBP shows preference for C/G-rich DNA sequences in vitro. Exp Parasitol (2009) 0.77
Synthesis and antifungal activity of diverse C-2 pyridinyl and pyridinylvinyl substituted quinolines. Bioorg Med Chem (2012) 0.77
Detection of synergistic combinations of Baccharis extracts with terbinafine against Trichophyton rubrum with high throughput screening synergy assay (HTSS) followed by 3D graphs. Behavior of some of their components. Phytomedicine (2013) 0.76
Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion. Mol Cell Biochem (2002) 0.76
Penetratin analogues acting as antifungal agents. Eur J Med Chem (2010) 0.76
Structure-antifungal activity relationship of His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 and analogues. Bioorg Med Chem (2008) 0.76
Cytotoxic and Antifungal Activities of Diverse α-Naphthylamine Derivatives. Sci Pharm (2012) 0.75
One- and two-hybrid analysis of the interactions between components of the Trypanosoma cruzi spliced leader RNA gene promoter binding complex. Int J Parasitol (2008) 0.75
Subcutaneous antifungal screening of Latin American plant extracts against Sporothrix schenckii and Fonsecaea pedrosoi. Pharm Biol (2011) 0.75
In vitro inhibition of 1,3-beta-glucan synthase by glycolipids from convolvulaceous species. Planta Med (2002) 0.75
Synthesis of steroidal quinones and hydroquinones from bile acids by Barton radical decarboxylation and benzoquinone addition. Studies on their cytotoxic and antifungal activities. Steroids (2011) 0.75
Penetratin and derivatives acting as antifungal agents. Eur J Med Chem (2008) 0.75
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment. Bioorg Med Chem (2007) 0.75
New antifungal peptides. Synthesis, bioassays and initial structure prediction by CD spectroscopy. Bioorg Med Chem Lett (2010) 0.75
Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi. Parasitol Int (2012) 0.75
Antifungal terpenoids from Hyalis argentea var. latisquama. J Nat Prod (2014) 0.75
Structural requirements for the antifungal activities of natural drimane sesquiterpenes and analogues, supported by conformational and electronic studies. Molecules (2013) 0.75